3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
44
Polycystic Ovary Syndrome
10
Breast Diseases
4
Advanced Breast Cancer
4
Infertility
3
Recurrence
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Infertility, Female
2
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1
Vitamin D Deficiency
1
Uterine Cervical Neoplasms
1
Solid Tumor
1
Pathologic Processes
1
Obesity
1
Myofibroma
1
Locally Advanced Breast Cancer
1
Hypoxia
1
Hydatidiform Mole
1
HER2+ Breast Cancer
1
Gestational Trophoblastic Disease
1
Endometrioid Endometrial Cancer
1
Endometrial Neoplasms
1
ER Positive, HER2 Negative Breast Cancer
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Organoids
1
Anovulation
1
Interventions
Metformin
2
Ultrasonography
1
Letrozole
1
Hematologic Tests
1
Clomiphene
1
Chorionic Gonadotropin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anovulation
×
Letrozole
×
Clear all
NCT02551367
2015-09-16
LVCCFOROI
Ain Shams Maternity Hospital
Phase 2
Unknown
110 enrolled